Atlas Trials

NovelMed Therapeutics

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NovelMed Therapeutics

RecordFirmDate
Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN) (NCT06454110)NovelMed Therapeutics2028-02-01
Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy (NCT05684159)NovelMed Therapeutics2027-11-01
Study of NM8074 in Adult C3 Glomerulopathy Patients (NCT05647811)NovelMed Therapeutics2027-05-01
Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris (NCT05646563)NovelMed Therapeutics2027-01-01
Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT05731050)NovelMed Therapeutics2026-06-01
Study of NM8074 in Patients with Dermatomyositis (DM) (NCT06887738)NovelMed Therapeutics2026-06-01
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) (NCT06226662)NovelMed Therapeutics2026-06-01
Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy (NCT05646524)NovelMed Therapeutics2026-04-01
First-in-Human (FIH) Clinical Study of NM8074 in Healthy Adult Volunteers (NCT05642546)NovelMed Therapeutics2020-08-12

Track NovelMed Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.